Lund University invites applications for CanFaster PhD program. The program is co funded by EU and it is a four-year doctoral program, within cancer research and entrepreneurship. The aim is to faster forward the discoveries in cancer research, to speed up the time from discovery to clinical practice.
About the CanFaster- PhD program:
- The candidates will undertake a comprehensive training programme, that includes courses in entrepreneurship, innovation processes, as well as education in clinical aspects of cancer and attend seminar series at the business incubator.
- The CanFaster students will be offered secondments in the non-academic sector, such as clinic or industry.
- The program is administrated by CREATE Health, located in the energetic and dynamic science park, Medicon Village, and the research will be conducted at Faculty of Engineering, Faculty of Medicine, as well as Social Sciences at Lund University in Sweden.
16 projects in Cancer and Entrepreneurship: A EU Horizon 2020 Marie Skłodowska-Curie COFUND programme
- Molecular investigations of mantle cell lymphoma and development of companion diagnostic tools
Research subject: Immunotechnology
- Novel Methods for Diagnosis of Clear Cell Renal Cell Carcinoma
Research subject: Laboratory medicine
- The role of microRNAs in Homing and Seeding of Prostate Cancer Metastases in Bone
Research subject: Laboratory medicine – Medical Molecular biology.
- Precision medicine for advanced cancers through molecular genomics and analysis of circulating tumour DNA
Research subject: Biomedicine – cancer genomics
- Molecular diagnostics for precision medicine – Development and application of the protein biomarker discovery platform GPS (Global Proteome Survey)
Research subject: Immunotechnology
- Patient stratification through affinity-based proteomics of liquid and tissue biopsies
Research subject: Immunotechnology
- Dendritic Cell Subsets in Head and Neck Cancers
Research subject: Immunotechnology
- Paediatric Brain Tumour Immunology and Immunotherapy
Research subject: Biomedicine – Cancer-Immunotherapy
- CRISPR/Cas9 Screens to Identify New Therapeutic Targets in Leukaemia
Research subject: Laboratory medicine
- Psychological Resilience – Emotion Regulation, Quality of Life and Biomolecular Fingerprints
Research subject: Psychology
- Development of novel targeted therapies against acute myeloid leukemia and novel tools for prediction of treatment efficacy
Research subject: Laboratory medicine – Molecular medicine.
- Delineating the Cellular Taxonomy of the Cancer Microenvironment
Research subject: Laboratory medicine
- Studies of tumour cell stress adaptation for the identification of new treatment targets
Research subject: Biomedicine – Experimental Oncology
- PROTECT women by PReventiOn and early deTECTion of breast cancer initiation – cellular and molecular effects of reducing breast density
Research subject: Biomedicine – Experimental Oncology
- Understanding genetic predisposition for multiple myeloma
Research subject: Laboratory medicine
- Translating genomic discoveries into improved clinical decision making, mechanistic understanding, and therapy of acute leukaemia
Research subject: Laboratory medicine -Experimental clinical genetics
Requirements:
- Applicant must have been awarded a second-cycle qualification, or has satisfied the requirements for courses comprising at least 240 credits of which at least 60 credits were awarded in the second cycle, or has acquired substantially equivalent knowledge in some other way in Sweden or abroad.
- Applicant must possess very good proficiency in English (oral and written).
- Applicant must have performed an independent research project.
How to Apply:
Applications to be written in English and must include the following:
- Cover letter describing the reasons why he/she is interested in the position and in what way the research project corresponds to the interests and educational background.
- CV
- Degree certificate or equivalent
- Any other documents applicant wishes to be considered.
- Scanned copies of the complete (Bachelor and Master equivalent) and official academic transcripts in English
- 2 reference letters; to be sent to canfaster@immun.lth.se with the subject Referee form and name of the applicant before the 17th of November 2017.
- Scanned copy of standardized test results (GRE, TOEFL, etc.).
- Applicant will be asked to prioritise top three research projects, and inform if he/she is interested to be offered another position than one of the top three.
- Applicant will be asked to answer a number of evaluation questions when submitting the application.
—————–Quick Overview————- | |
Organization | Lund University |
Fellowship Level | Doctoral |
Country | Sweden |
Subject areas | Biosciences, Cancer Research, Immunology |
Fellowship amount | Varies |
Eligibility | Open to all nationalities |
Deadline | 17 November 2017 |
———————————— |